76 related articles for article (PubMed ID: 1696630)
1. Compensatory activation of substance P biosynthesis by L-dihydroxyphenylalanine in striatonigral neurons of neonatal dopaminergic denervated rats.
Sivam SP; Krause JE
J Pharmacol Exp Ther; 1990 Aug; 254(2):433-9. PubMed ID: 1696630
[TBL] [Abstract][Full Text] [Related]
2. Dopaminergic regulation of tachykinin metabolism in the striatonigral pathway.
Li SJ; Sivam SP; McGinty JF; Huang YS; Hong JS
J Pharmacol Exp Ther; 1987 Nov; 243(2):792-8. PubMed ID: 2445959
[TBL] [Abstract][Full Text] [Related]
3. L-DOPA-induced activation of striatal p38MAPK and CREB in neonatal dopaminergic denervated rat: relevance to self-injurious behavior.
Sivam SP; Pugazhenthi S; Pugazhenthi V; Brown H
J Neurosci Res; 2008 Feb; 86(2):339-49. PubMed ID: 17893915
[TBL] [Abstract][Full Text] [Related]
4. Effect of repeated L-DOPA, bromocriptine, or lisuride administration on preproenkephalin-A and preproenkephalin-B mRNA levels in the striatum of the 6-hydroxydopamine-lesioned rat.
Henry B; Crossman AR; Brotchie JM
Exp Neurol; 1999 Feb; 155(2):204-20. PubMed ID: 10072296
[TBL] [Abstract][Full Text] [Related]
5. Cocaine selectively increases striatonigral dynorphin levels by a dopaminergic mechanism.
Sivam SP
J Pharmacol Exp Ther; 1989 Sep; 250(3):818-24. PubMed ID: 2476548
[TBL] [Abstract][Full Text] [Related]
6. Different responsiveness of striatonigral and striatopallidal neurons to L-DOPA after a subchronic intermittent L-DOPA treatment.
Carta AR; Tronci E; Pinna A; Morelli M
Eur J Neurosci; 2005 Mar; 21(5):1196-204. PubMed ID: 15813929
[TBL] [Abstract][Full Text] [Related]
7. MK-801 alters the effects of priming with L-DOPA on dopamine D1 receptor-induced changes in neuropeptide mRNA levels in the rat striatal output neurons.
Van De Witte SV; Groenewegen HJ; Voorn P
Synapse; 2002 Jan; 43(1):1-11. PubMed ID: 11746728
[TBL] [Abstract][Full Text] [Related]
8. Differential regulation of GAD67, enkephalin and dynorphin mRNAs by chronic-intermittent L-dopa and A2A receptor blockade plus L-dopa in dopamine-denervated rats.
Carta AR; Pinna A; Cauli O; Morelli M
Synapse; 2002 Jun; 44(3):166-74. PubMed ID: 11954048
[TBL] [Abstract][Full Text] [Related]
9. D1 dopamine receptor-mediated substance P depletion in the striatonigral neurons of rats subjected to neonatal dopaminergic denervation: implications for self-injurious behavior.
Sivam SP
Brain Res; 1989 Oct; 500(1-2):119-30. PubMed ID: 2481560
[TBL] [Abstract][Full Text] [Related]
10. L-DOPA-induced dyskinesia in the rat is associated with striatal overexpression of prodynorphin- and glutamic acid decarboxylase mRNA.
Cenci MA; Lee CS; Björklund A
Eur J Neurosci; 1998 Aug; 10(8):2694-706. PubMed ID: 9767399
[TBL] [Abstract][Full Text] [Related]
11. The adaptation of enkephalin, tachykinin and monoamine neurons of the basal ganglia following neonatal dopaminergic denervation is dependent on the extent of dopamine depletion.
Sivam SP; Krause JE
Brain Res; 1990 Dec; 536(1-2):169-75. PubMed ID: 1707718
[TBL] [Abstract][Full Text] [Related]
12. Blockade of A2A receptors plus l-DOPA after nigrostriatal lesion results in GAD67 mRNA changes different from l-DOPA alone in the rat globus pallidus and substantia nigra reticulata.
Carta AR; Tabrizi MA; Baraldi PG; Pinna A; Pala P; Morelli M
Exp Neurol; 2003 Dec; 184(2):679-87. PubMed ID: 14769359
[TBL] [Abstract][Full Text] [Related]
13. Lithium increases rat striatal beta- and gamma-preprotachykinin messenger RNAs.
Sivam SP; Krause JE; Takeuchi K; Li S; McGinty JF; Hong JS
J Pharmacol Exp Ther; 1989 Mar; 248(3):1297-301. PubMed ID: 2467980
[TBL] [Abstract][Full Text] [Related]
14. Dopaminergic functional supersensitivity: effects of chronic L-dopa and carbidopa treatment in an animal model of Parkinson's disease.
Hossain MA; Weiner N
J Pharmacol Exp Ther; 1993 Dec; 267(3):1105-11. PubMed ID: 8263772
[TBL] [Abstract][Full Text] [Related]
15. Postnatal administration of D1 dopamine agonist reverses neonatal dopaminergic lesion-induced changes in striatal enkephalin and substance P systems.
Sivam SP; Cox J
Brain Res; 2006 Feb; 1073-1074():159-63. PubMed ID: 16455064
[TBL] [Abstract][Full Text] [Related]
16. Tachykinin systems in the spinal cord and basal ganglia: influence of neonatal capsaicin treatment or dopaminergic intervention on levels of peptides, substance P-encoding mRNAs, and substance P receptor mRNA.
Sivam SP; Krause JE
J Neurochem; 1992 Dec; 59(6):2278-84. PubMed ID: 1279124
[TBL] [Abstract][Full Text] [Related]
17. Dopamine receptors: effects of chronic L-dopa and bromocriptine treatment in an animal model of Parkinson's disease.
Schneider MB; Murrin LC; Pfeiffer RF; Deupree JD
Clin Neuropharmacol; 1984; 7(3):247-57. PubMed ID: 6435870
[TBL] [Abstract][Full Text] [Related]
18. Denervation and repeated L-DOPA induce complex regulatory changes in neurochemical phenotypes of striatal neurons: implication of a dopamine D1-dependent mechanism.
St-Hilaire M; Landry E; Lévesque D; Rouillard C
Neurobiol Dis; 2005 Nov; 20(2):450-60. PubMed ID: 15896973
[TBL] [Abstract][Full Text] [Related]
19. Dopaminergic regulation of striatonigral tachykinin and dynorphin gene expression: a study with the dopamine uptake inhibitor GBR-12909.
Sivam SP
Brain Res Mol Brain Res; 1996 Jan; 35(1-2):197-210. PubMed ID: 8717356
[TBL] [Abstract][Full Text] [Related]
20. Dopamine-dependent postnatal development of enkephalin and tachykinin neurons of rat basal ganglia.
Sivam SP; Krause JE; Breese GR; Hong JS
J Neurochem; 1991 May; 56(5):1499-508. PubMed ID: 1707436
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
